Clinical expansion FoodMarble has a clear pathway from consumer wellness to clinical market adoption, including ongoing trials at Johns Hopkins and healthcare professional platforms. A sales opportunity lies in partnering with gastroenterology clinics, hospitals, and private practices to deploy portable breath testing as part of IBS and SIBO management programs.

Healthcare partnerships The FoodMarble Healthcare platform enables clinicians to use portable breath testing for diagnosis and monitoring. Target health systems, gastroenterology groups, and analytics-enabled care networks to co-create value through integrated patient monitoring, data sharing, and remote patient engagement.

Enterprise data play With precision hydrogen and methane sensors and a clinician-oriented ecosystem, there is potential to offer white-labeled or integrated data solutions, dashboards, and API access for research cohorts, pharma studies, and contract-based clinical trials.

Market education Recent feature launches like FoodScanner indicate ongoing product development. A proactive sales approach can emphasize portability, patient-friendly testing, and faster diagnostic workflows to drive adoption among clinics seeking modern digital diagnostics.

Growth and funding Financing of about 8.7M and a trajectory from R&D to market entry suggests readiness for scaled partnerships. Coordinate co-marketing, joint field deployments, and clinical study sponsorships to accelerate revenue streams and market penetration.